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ABSTRACT The life cycle of human papillomaviruses (HPVs) comprises three distinct
phases of DNA replication: initial amplification, maintenance of the genome copy
number at a constant level, and vegetative amplification. The viral helicase E1 is one
of the factors required for the initiation of HPV genome replication. However, the
functions of the E1 protein during other phases of the viral life cycle are largely un-
characterized. Here, we studied the role of the HPV18 E1 helicase in three phases of
viral genome replication by downregulating E1 expression using RNA interference or
inducing degradation of the E1 protein via inhibition of casein kinase 2 expression
or catalytic activity. We generated a novel modified HPV18 genome expressing Na-
noluc and tagged E1 and E2 proteins and created several stable HPV18-positive cell
lines. We showed that, in contrast to initial amplification of the HPV18 genome,
other phases of viral genome replication involve also an E1-independent mecha-
nism. We characterize two distinct populations of HPV18 replicons existing during
the maintenance and vegetative amplification phases. We show that a subset of
these replicons, including viral genome monomers, replicate in an E1-dependent
manner, while some oligomeric forms of the HPV18 genome replicate independently
of E1 function.
IMPORTANCE Human papillomavirus (HPV) infections pose serious medical problem.
To date, there are no HPV-specific antivirals available due to poor understanding of
the molecular mechanisms of virus infection cycle. The infection cycle of HPV in-
volves initial amplification of the viral genomes and maintenance of the viral ge-
nomes with a constant copy number, followed by another round of viral genome
amplification and new viral particle formation. The viral protein E1 is critical for the
initial amplification of the viral genome. However, E1 involvement in other phases of
the viral life cycle has remained controversial. In the present study, we show that at
least two different replication modes of the HPV18 genome are undertaken simulta-
neously during the maintenance and vegetative amplification phases, i.e., replication
of the majority of the HPV18 genome proceeds under the control of the host cell
replication machinery without E1 function, whereas a minority of the genome repli-
cates in an E1-dependent manner.
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Human papillomaviruses (HPVs) are epitheliotropic viruses with a double-strandedcircular DNA genome of 8,000 bp. The infectious cycle of HPVs can be divided
into three distinct stages. First, following the infection of proliferating keratinocytes in
the basal layer of the epithelium, the unpacked viral genome enters the nucleus and
becomes transcriptionally active. The early viral genes E1 and E2 are activated during
this stage of infection, leading to the expression of viral proteins required for the
efficient transcription and replication of the viral genome. Then, the expression of viral
oncogenes E6 and E7 is initiated. The viral genome is amplified during this stage,
usually reaching approximately 100 to 500 copies per cell. One of the consequences of
Citation Piirsoo A, Kala M, Sankovski E, Ustav M,
Piirsoo M. 2020. Uncovering the role of the E1
protein in different stages of human
papillomavirus 18 genome replication. J Virol
94:e00674-20. https://doi.org/10.1128/JVI
.00674-20.
Editor Lawrence Banks, International Centre
for Genetic Engineering and Biotechnology
Copyright © 2020 American Society for
Microbiology. All Rights Reserved.
Address correspondence to Alla Piirsoo,
alla.piirsoo@ut.ee.
Received 10 April 2020
Accepted 22 July 2020
Accepted manuscript posted online 5
August 2020
Published
GENOME REPLICATION AND REGULATION
OF VIRAL GENE EXPRESSION
crossm
October 2020 Volume 94 Issue 20 e00674-20 jvi.asm.org 1Journal of Virology
29 September 2020












the expression of HPV oncogenes is that the infected keratinocytes are retained in the
cell cycle, which allows the initiation of the second stage of the viral life cycle, persistent
infection, during which the HPV DNA replicates in concert with the cellular DNA, and
the copy number of the viral genome remains constant. The third stage of the PV life
cycle is initiated in the terminally differentiated keratinocytes of the upper layers of the
stratified epithelium. It involves vegetative amplification of the viral genome and
expression of viral capsid proteins, followed by the formation of new infectious
particles (reviewed in reference 1).
The viral factors required for the initial amplification of the HPV genome, have
been extensively studied. It has been found that three viral elements are needed
during the initial amplification of the HPV genome. The replication origin is situated
in the noncoding region of the virus genome, and the viral proteins E1 and E2 act
as trans-factors to initiate replication from this origin (reviewed in reference 2). E2
is a sequence specific transcription factor (3). It binds to the viral origin and recruits
the initiator protein E1 to DNA (4, 5). E1 is a DNA helicase that engages the cellular
replication machinery to start bidirectional replication of the viral genome (6, 7). As
replication is initiated from the viral origin repeatedly during the S phase, the copy
number of the HPV genome increases in cells.
Much less is known about the maintenance replication of the HPV genome during
persistent infection. Several observations suggest that the mechanism might be differ-
ent than that of the initial amplification. First, as mentioned above, the copy number
of the viral genome does not change over cell generations (2). The question of whether
the maintenance replication of the HPV genome is under the control of the cellular
origin licensing machinery and restricted to one replication per cell cycle, or whether
replication is statistically completed once per cell cycle, has remained obscure, since
both options have been proposed (8, 9). Second, it has been shown that a novel mode
of replication is initiated already during the transient replication of the viral genome, as
determined by two-dimensional (2D) gel electrophoresis analysis of replication inter-
mediates (10, 11). The exact nature of this novel mode of replication has remained
enigmatic, but it has been suggested to involve cellular recombination-dependent
replication machinery (10). Third, and possibly connected to the observation of the
intermediates, is that the episomal HPV genomes tend to form oligomeric concatemer
structures in patient derived and established cell lines, which means that the size and
structure of the viral replicons might be different than the viral genome that initially
infects the cells (12–15).
Molecular aspects of the replication of HPV genome during the third stage of the
infection cycle have also remained largely uncharacterized due to the lack of upscalable
cell culture systems, since replication normally takes place only in terminally differen-
tiated cells. Several studies have indicated that the vegetative replication of viral
genome is dependent on the cellular DNA damage response (DDR) pathway (16–19).
There is no clear consensus about the mode of this replication phase of HPV genome,
as it has been proposed to proceed by the rolling circle or bidirectional mechanism
(20, 21).
The extent of the dependence of viral genome replication on the viral initiator
protein and helicase E1 during the maintenance and vegetative phases has remained
unclear. It has been shown that HPV31 E1 is required for maintenance replication, while
HPV16 E1 is dispensable (9, 22–24). In addition, while the expression of HPV31 E1 is
dramatically induced at the onset of keratinocyte differentiation, it has been proposed
that vegetative amplification of viral genome takes place with cellular DDR proteins, for
which the role of E1 remains unknown (17, 25–27).
Here, we examine the role of the HPV18 E1 protein in all three stages of the viral
genome replication. We utilize U2OS cells, which are permissive for the replication of
different HPV types. U2OS cells are not natural hosts for HPV, but they effectively
recapitulate transient amplification, maintenance replication, and vegetative amplifica-
tion of viral genomes (28). Also, the transcript maps of various HPV genomes in U2OS
cells are very similar to those of the HPV genomes in keratinocytes (29–31). Further-
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more, these cells constitute a well-established model system used to study the DDR
response, a cellular function that is required for HPV replication (see reference 32 and
references therein).
Here, we show that two distinct populations of viral replicons exist during the
maintenance and vegetative amplification phases of HPV18 genome replication. Using
E1 RNA interference (RNAi) and inhibition of cellular casein kinase 2 (CK2) activity, we
demonstrate that a subset of these replicons, including viral genome monomers,
replicates in an E1-dependent manner, while some oligomeric forms replicate inde-
pendently of E1 function.
RESULTS
The modified HPV18 genome and its wild-type counterpart replicate similarly.
Despite the fact that the U2OS cell line efficiently supports replication of HPV genomes,
it has been very difficult to analyze the expression of the endogenous viral replication
proteins E1 and E2 due to their very low expression levels and the lack of specific
antibodies.
To enable the detection of the endogenous E1 and E2 proteins and facilitate the
analysis of the replication efficiency of HPV18 DNA, we generated an HPV18-E1HA-
Nluc-E2Flag genome possessing several modifications (Fig. 1A). First, the sequences
encoding the codon-optimized Nanoluc (Nluc) and the self-processed peptide 2A were
inserted in frame with E2 immediately after the E1 stop codon. The full-length E2 open
reading frame (ORF) is followed by the sequence encoding the 2A peptide. Second, the
sequences encoding the hemagglutinin (HA) and Flag tags were inserted into the E1
and full-length E2 ORFs, respectively. The HA tag was inserted after the fifth amino acid
of E1. The Flag tag was introduced in front of the second amino acid of the full-length
E2. Thus, the HPV18-E1HA-Nluc-E2Flag genome expresses the HA-tagged E1, Nluc
protein fused with 24 amino acids of the truncated E2 N-terminally and the 2A peptide
C terminally, and the Flag-tagged full-length E2.
Analysis of HPV18 transcripts has shown that all viral pre-mRNAs are polycistronic
with a complex splicing pattern (29, 33). Exogenous sequences introduced into the viral
genome could potentially change this pattern and alter the replication efficiency of the
modified genome. In addition, the modified proteins may possess altered biological
activity. Therefore, we compared the replication efficiency of the HPV18-E1HA-Nluc-
E2Flag and the HPV18 wild-type (WT) genomes in U2OS cells. Southern blotting (SB)
showed that both genomes replicated with similar efficiency (Fig. 1B, C, and D, left
panel). Quantification of the SB results and comparison of these results with the Nluc
activity data measured in the same samples showed that both signals correlated well
(R2  0.963) and increased over time with similar kinetics (Fig. 1D and E). These results
confirm the previously demonstrated data verifying Nluc activity as a suitable tool for
estimating the replication efficiency of Nluc-positive HPV genomes (34, 35).
E1 RNAi inhibits the initial amplification of HPV18. The viral helicase E1 has been
proven to be absolutely required for the initiation of HPV replication from the viral
origin of replication (2). Therefore, to verify our experimental model, we analyzed the
impact of E1 RNAi on the initial amplification of the HPV18 genome using transiently
transfected U2OS cells.
First, we analyzed the levels of endogenous E1 and E2 proteins in U2OS cells
cotransfected with the HPV18-E1HA-Nluc-E2Flag genome and two E1-specific siRNAs.
At 4 days posttransfection, the E1 and E2 proteins were immunoprecipitated and
analyzed using Western blotting (WB) (Fig. 2A). Both E1 siRNAs effectively inhibited E1
protein expression. Quantification of the WB results showed that the level of the
endogenous E1 protein was reduced more than 90 and 99% by E1 siRNA1 and siRNA2,
respectively (Fig. 2B). E1 RNAi inhibited not only E1 but also E2 expression approxi-
mately 90% (Fig. 2A and B).
One interpretation of these results suggests that the E1 and E2 proteins are
translated from the same transcript. The HPV18 transcription maps show that while
only one of the HPV18 transcripts encodes E1, four could potentially code the E2
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protein. Alternatively, it is possible that E1 stabilizes the E2 protein, as is shown in the
case of HPV16 (36), since both proteins form a complex in solution, and we detected
the E1 protein in the E2 immuno-complexes (Fig. 2A).
To test whether E1 is required for the maintenance of the E2 protein level in cells,
we analyzed the levels of the E1 and E2 proteins in the U2OS cells transfected with the
HPV18-E1HA-Nluc-E2Flag genome and subsequently treated with CX4945, a small
molecular inhibitor of CK2 kinase. We have previously shown that the catalytic activity
of CK2 kinase is required for the stability of the E1 protein but it has no effect on E1
transcription (34). Indeed, the E1 protein level was gradually reduced in response to
CX4945, as assessed by immunoblotting assay (Fig. 2C). However, the E2 protein was
readily detectable in the cells lacking the E1 protein. Quantification of the WB signals
showed that although the E1 protein level was reduced more than 99% after 48 h of
treatment with CX4945, the E2 protein was downregulated approximately 25% during
the course of the experiments (Fig. 2D). These data indicate that neither the deficiency
of the CK2 catalytic activity nor lack of the E1 protein has a dramatic effect on E2
protein stability.
Next, we analyzed the impact of E1 RNAi on the replication efficiency of the
HPV18-E1HA-Nluc-E2Flag genome using a luciferase assay. E1 RNAi-induced reduc-
FIG 1 The replication efficiency of the HPV18-E1HA-Nluc-E2Flag genome is similar to that of the WT HPV18. (A) Map of the HPV18-E1HA-
Nluc-E2Flag genome. Red indicates the position of the tags in the E1 and E2 ORFs. The sequence of Nluc is immediately after 72 nucleotides
of the WT E2 ORF, which overlaps with the 3= end of the E1-HA ORF. The full-length E2 ORF containing the Flag tag sequence follows
immediately after the sequence encoding the self-processing 2A peptide situated in the 3= end of the E2-Nluc ORF (not shown). (B)
Transient replication of the HPV18 and HPV18-E1HA-Nluc-E2Flag genomes in the U2OS cells was analyzed using SB. Total DNA was treated
with BglI and DpnI restriction enzymes. (C and D, left panel) SB signals corresponding to the replicated HPV18 (C) and HPV18-E1HA-Nluc-
E2Flag genome (D) were quantified using ImageQuant software. The percent intensity was calculated for each sample relative to the
signals obtained in the 2-day posttransfection cells. (D, right panel) The samples obtained from the cells transfected with HPV18-E1HA-
Nluc-E2Flag were analyzed for Nluc activity, which was normalized by the activity of alkaline phosphatase and set as 100% for the
2-day-posttransfection cells (*, P  0.05; **, P  0.01; n  3). (E) U2OS cells were transfected with the HPV18-E1HA-Nluc-E2Flag genome
and incubated for 2, 3, and 4 days. Linear regression of the normalized Nluc activity and quantified SB signals was analyzed using GraphPad
software. The data are expressed as percentages  the standard deviations (SD) of the signals obtained in the cells incubated for 2 days
(set as 100%).
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FIG 2 E1 RNAi restrains the transient replication of the modified HPV18 genomes in the U2OS cells. (A) U2OS cells were transfected with either the HPV18 or
HPV18-E1HA-Nluc-E2Flag genome in the presence of E1-specific or Neg. siRNAs. The cells were incubated for 4 days. The endogenous HA-tagged E1 and
Flag-tagged E2 proteins were immunoprecipitated and analyzed using WB and anti-tag antibodies. E1 was also detected in E2 immunocomplexes. GAPDH was
used as a control. (B) WB signals corresponding to the E1-HA and E2-Flag protein levels were quantified and expressed as percentages of the E1-HA and E2-Flag
levels, respectively, obtained in the samples transfected with Neg. siRNA (indicated as 100%). The data are expressed as average means  the SD (***, P  0.001;
n  4). (C) The U2OS cells were transfected with the HPV18-E1HA-Nluc-E2Flag or HPV18 WT genome, incubated for 3 days, and treated with DMSO or 9 M
CX4945 for 12, 24, or 48 h. Endogenous E1 and E2 proteins were immunoprecipitated and analyzed using WB and tag-specific antibodies. (D) WB signals
corresponding to the E1-HA and E2-Flag protein levels were quantified and expressed as percentages of the E1-HA and E2-Flag levels, respectively, obtained
(Continued on next page)
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tion in the E2 protein level was compensated by overexpressed Flag-tagged E2. In
addition, we cotransfected the genome with the construct encoding HA-tagged E1
to estimate the efficiency of the established E1 RNAi experimental settings for
higher expression levels of E1. Nluc activity was measured at 2, 3, and 4 days
posttransfection and normalized to alkaline phosphatase activity (Fig. 2E).
In the control cells, the overexpression of E1 and E2 enhanced the HPV18-E1HA-
Nluc-E2Flag replication efficiency, as indicated by the Nluc activity increase over time.
The E1 RNAi led to the inability of the HPV18-E1HA-Nluc-E2Flag genome to replicate
since the Nluc activity remained at its initial level during the course of the experiment.
This effect also persisted in the presence of the overexpressed E1 and E2, showing that
E1 RNAi is completely functional in the case of overexpressed E1 and E2.
These results were corroborated by the data from SB analysis to determine the
replication efficiency of the HPV18-E1HA genome in the presence of E1 siRNAs and
exogenous E2 (Fig. 2F). Very faint replication signals were obtained in the case of the
less-effective E1 siRNA1, while more potent E1 siRNA2 completely abolished HPV18-
E1HA replication. The cell cycle-specific effects of E1 RNAi were excluded by the analysis
of the cell cycle profile in the U2OS cells cotransfected with the HPV18-E1HA genome
and E1 siRNAs and incubated for 2, 4 and 6 days (Fig. 2G). The E1 RNAi had no effect
on the cell cycle. Taken together, our results confirm previous data showing that E1 is
absolutely required for the initial phase of HPV18 DNA replication.
E1 expressed from the siRNA-resistant ORF rescues the E1 RNAi-induced phe-
notype. To analyze the specificity of the observed E1 RNAi-mediated effects, we
introduced silent mutations into the E1 siRNA-specific sequences to generate the
constructs expressing E1-siRNA1-R and E1-siRNA2-R full-length transcripts resistant to E1
siRNA1 and siRNA2, respectively. WB analysis showed that the expression levels of the
overexpressed E1-HA proteins encoded by WT or mutant constructs were similar in
U2OS cells (Fig. 3A). The biological activity of the overexpressed E1-HA proteins was
tested in U2OS cells using luciferase assay. The cells were cotransfected with the
HPV18-Nluc genome and the constructs encoding the E1-HA proteins; incubated for 2,
3, and 4 days; and subjected to the luciferase assay. The E1-HA proteins expressed by
the E1-WT, E1-siRNA1-R, and E1-siRNA2-R constructs demonstrated similar activity by
increasing the HPV18-Nluc copy number 2-fold (Fig. 3B). Next, the generated con-
structs were subjected to the E1 RNAi to examine their resistance to the E1 siRNAs.
U2OS cells were cotransfected with the E1-siRNA1-R or E1-siRNA2-R expression con-
structs and E1 siRNAs, incubated for 3 days, and subjected to WB analysis (Fig. 3C). The
E1-siRNA1-R transcript was resistant to E1 siRNA1, allowing expression of the E1-HA
protein, but it remained sensitive to the E1 siRNA2. In the case of the E1-siRNA1-R
construct, E1-HA protein was detected in the presence of E1 siRNA2, but E1 siRNA1
interfered with the expression. These data indicate that the introduced silent mutations
prevent efficiently degradation of the E1-HA encoding transcripts by the respective E1
siRNAs.
Next, we examined the ability of the overexpressed E1-HA proteins to compensate
for the E1 RNAi-mediated inhibition of the HPV18-Nluc replication in U2OS cells
(Fig. 3D). U2OS cells were transfected with the HPV18-Nluc genome, E1 siRNAs and
E1-siRNA-resistant constructs, or empty vector. The cells were incubated for 2, 3, and
4 days. The luciferase assay showed that the E1-siRNA1-R protein was able to reverse
the E1 siRNA1-induced inhibition of the HPV18-Nluc replication but not the inhibitory
FIG 2 Legend (Continued)
in the samples treated with DMSO (indicated as 100%). The data are expressed as average means  the SD (*, P  0.05; ***, P  0.001; n  4). (E) U2OS cells
were cotransfected with the HPV18-E1HA-Nluc-E2Flag genome, E1-specific or Neg. siRNA, and the constructs encoding either E1 or E2 of HPV18. Cells were
incubated for 2, 3, or 4 days and subjected to luciferase assay. The Nluc activity was normalized to the activity of AP. The data are shown as a percentage of
the normalized Nluc activity obtained in the cells transfected with the HPV18-E1HA-Nluc-E2Flag genome, Neg. siRNA and empty vector and incubated for 2 days
(set as 100%) (for statistical analysis, data of each sample was compared to the data of the respective control at the same time point [**, P  0.01; ***, P 
0.001; n  3]). (F) U2OS cells were transfected with the HPV18-E1HA genome, E1-specific or Neg. siRNA, and E2-encoding construct. Total DNA was isolated from
2-, 3-, and 4-day-posttransfection cells, treated with BglI and DpnI restriction endonucleases and subjected to SB. (G) Cell cycle profile of the U2OS cells
cotransfected with the HPV18-E1HA genome and the siRNAs was analyzed using PI.
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FIG 3 E1 RNAi is responsible for the suppression of the HPV18 replication. (A) U2OS cells were transfected with the constructs expressing HPV18 E1-WT,
E1-siRNA1-R, and E1-siRNA2-R transcripts. E1-siRNA1-R and E1-siRNA2-R ORFs contain silent mutations to generate resistance for E1 siRNA1 and siRNA2,
respectively. Housekeeping GAPDH and overexpressed E1-HA proteins were analyzed using WB. (B) U2OS cells were cotransfected with the HPV18-Nluc genome
and different E1-HA expression constructs or an empty vector in quadruplicates. The cells were incubated for 2, 3, and 4 days and subjected to a luciferase assay.
The Nluc activity was normalized to the total protein amount and set as 100% in the control cells cotransfected with the genome and empty vector and
incubated for 2 days. The data are shown as average means  the SD (n  2). (C) E1-siRNA1-R and E1-siRNA2-R constructs were cotransfected with the E1 siRNAs
into U2OS cells. After 3 days of transfection, GAPDH and E1-HA proteins were analyzed using immunoblotting. (D) U2OS cells were cotransfected with the
HPV18-Nluc genome, E1 siRNAs, and E1-siRNA1-R and E1-siRNA2-R expression constructs in quadruplicates; incubated for 2, 3, and 4 days; and analyzed using
luciferase assay. Nluc activity was normalized to the total protein amount and set as 100% in the control cells cotransfected with the genome, empty vector
and Neg. siRNA and incubated for 2 days. The data are shown as average percentages of the control  the SD (**, P  0.01; ***, P  0.001; n  3). (E) U2OS
cells were transfected with the indicated HPV18 genomes and incubated for 2, 3, and 4 days. Total DNA was extracted, digested with BglI and DpnI restriction
enzymes, and analyzed using SB. (F) U2OS cells were cotransfected with either HPV18-E1HA-R1 or HPV18-E1HA-R2 genomes and Neg. or E1 siRNAs. Cells were
incubated for 3 days. E1-HA and GAPDH proteins were analyzed using WB. (G) U2OS cells were cotransfected with either HPV18-E1HA-R1 or HPV18-E1HA-R2
genomes, E1 siRNAs, and E1-siRNA1-R or E1-siRNA2-R expression constructs, if indicated. After 3 days of incubation, total DNA was extracted, treated with BglI
and DpnI restriction endonucleases, and subjected to SB analysis.
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effect of the E1 siRNA2. Also, the E1-siRNA2-R protein was able to compensate for the
HPV18-Nluc copy number reduction in response to E1 siRNA2, but it was inactive in
the presence of the E1 siRNA1. These data indicate that the E1 siRNA resistance of the
overexpressed E1 protein rescues the HPV18-Nluc copy number decrease induced by E1
RNAi that, in turn, verifies the E1-specific downregulation of the HPV18 replication.
To further corroborate the specificity of the E1 RNAi-dependent decrease in
HPV18 replication, we generated the HPV18-E1HA genomes expressing the E1-HA
protein from the transcripts resistant to either E1 siRNA1 or siRNA2. The silent
mutations introduced into the E1-HA ORF were identical to the once described for
the E1-siRNA1-R and E1-siRNA2-R expression constructs. SB analysis showed that
the generated HPV18-E1HA-R1 and HPV18-E1HA-R2 genomes replicated similarly
to the HPV18-E1HA genome in U2OS cells (Fig. 3E). To analyze the expression of the
E1-HA protein, U2OS cells were transfected with the HPV18-E1HA-R1 and HPV18-
E1HA-R2 genomes and E1 siRNAs. WB analysis showed that the introduced muta-
tions prevented E1 RNAi induced by the respective E1 siRNA (Fig. 3F). The E1-HA
protein was detected in the cells cotransfected with E1 siRNA1 and HPV18-E1HA-R1
genome or E1 siRNA2 and HPV18-E1HA-R2 genome. However, expression of E1-HA
was downregulated by another E1 siRNA. Next, we analyzed the replication effi-
ciency of the generated genomes cotransfected with E1 siRNAs and E1-siRNA1-R or
E1-siRNA2-R constructs in U2OS cells (Fig. 3G). The HPV18-E1HA-R1 genome repli-
cated in the presence of the E1 siRNA1 but failed to replicate in the cells treated
with E1 siRNA2. The HPV18-E1HA-R2 genome was resistant to E1 siRNA2, but E1
siRNA1 inhibited its replication. However, overexpression of the E1-HA proteins
from E1-siRNA1-R or E1-siRNA2-R constructs rescued the siRNA2- and siRNA1-
mediated downregulation of HPV18-E1HA-R1 and HPV18-E1HA-R2 genome replica-
tion, respectively. Taken together, these data confirm that the observed decrease in
HPV18 replication occurs specifically due to the E1 knockdown.
Establishment of the stable cell lines possessing modified HPV18 genomes. To
investigate the contribution of the E1 protein in stable replication, we used three stable
clonal cell lines bearing the modified HPV18 genomes replicating as multicopy epi-
somes. The cell line bearing the WT HPV18 genome (HPV18 cells) has been described
previously as Clone 1.13 (28). The cell line carrying the HPV18-E1HA genome (HPV18-
E1HA cells) is a derivative of U2OS cells. The cell line, which was positive for the
HPV18-Nluc genome (HPV18-Nluc cells), was generated from the U2OS-derived 10.15
cell line carrying the firefly luciferase gene stably incorporated in the genome (37).
To ascertain their stability, HPV18-E1HA and HPV18-Nluc cells were propagated
for approximately 2 months with regular subculturing. Total DNA was isolated at
different passages and analyzed for the status of the viral genome by SB (Fig. 4A). The
HPV18 genomes persisted at a stable level. We also measured the copy number of the
respective HPV18 genomes in our stable cell lines using quantitative PCR (qPCR). The
HPV18-Nluc cells had approximately 440 copies, the HPV18 cells carried approxi-
mately 290 copies, and the HPV18-E1HA cells had 80 copies of the viral genome per
cell.
To verify the episomal nature of the replicating HPV18 genomes, low-molecular-
weight (LMW) DNA was isolated from the HPV18-E1HA and HPV18-Nluc cells,
digested with three different restriction enzymes either linearizing or not cutting the
HPV18 genomes, and analyzed using SB (Fig. 4B). The pattern of differently linearized
or nondigested HPV18 genomes was similar, confirming the absence of the chromo-
somal integrations in both of these cell lines.
It has been previously reported that the copy number of HPV genomes increases in
stable cell lines propagated in dense culture (28). These conditions are suggested to
mimic those of the terminally differentiating keratinocytes, in which the vegetative
amplification phase of the HPV life cycle occurs. These observations were made using
HPV18 cells (28). To examine whether the above-described tendencies also occur in
the HPV18-E1HA and HPV18-Nluc cell lines, we propagated the cells for 2, 4, or
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FIG 4 U2OS cells support stable replication of the modified HPV18 genomes. (A) U2OS-derived HPV18-E1HA and HPV18-Nluc cells
containing the stably replicating HPV18-E1HA and HPV18-Nluc genomes, respectively, were cultured for approximately two months.
Total DNA was isolated at passages p2 to p12, treated with the restriction enzyme BglI linearizing the indicated HPV18 genomes, and
subjected to SB. (B) Prior to SB, the LMW DNA isolated from the nonconfluent HPV18-E1HA and HPV18-Nluc cells (left and right
panels, respectively) was treated with restriction endonucleases for either linearizing (lin) or not cutting (nc) the indicated modified
HPV18 genomes. lin1, BglI; lin2, BglII; lin3, SdaI; nc1, HindIII; nc2, SacI; nc3, ScaI. (C) After seeding, the HPV18-E1HA and HPV18-Nluc
stable cell lines were continuously propagated for 2, 4, and 7 days, resulting in nonconfluent, subconfluent, and confluent cultures,
respectively. The U2OS cells were transfected with the respective modified HPV18 genomes and cultured for the indicated periods of
time. Prior to SB, the isolated extrachromosomal DNA was treated with the restriction enzymes for either linearizing (BglI) or not
cutting (HindIII) the indicated HPV18 genomes and with DpnI in the case of the transiently replicating genomes. Numbers indicate
different forms of the uncut modified HPV18 DNA detected in the LMW DNA pool isolated from the confluent stable cell lines. ccc,
(Continued on next page)
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7 days without subculturing. The confluence of the cells reached 100% on day 4 after
passaging. LMW DNA was isolated, treated with the restriction endonucleases for either
linearizing or not cutting the HPV18 genomes, and analyzed using SB (Fig. 4C).
Both cell lines demonstrated an increase in the copy number of the viral genomes
during propagation in dense cultures (Fig. 4C, lanes 1 to 3). In addition, the oligomeric
nature of the viral genomes was confirmed. However, the pattern of the viral genome
oligomers changed in the confluent cells. A single oligomeric form of the HPV18-E1HA
genome could be observed in the subconfluent cells (Fig. 4C, left panel, lane 4), and this
form remained the most prevalent in the densely cultured cells (lanes 5 and 6).
However, multiple additional forms of viral DNA appeared in the highly confluent cells
(lane 6). Some of these forms of the viral genome migrated similarly to the respective
HPV18 genome monomers and oligomers found during transient replication (Fig. 4C,
lanes 7 and 8). Generally, the HPV18-Nluc cells demonstrated similar tendencies with
one exception: the multiple monomeric and oligomeric forms of the HPV18-Nluc
genome were also detectable in the nonconfluent cells (Fig. 4C, right panel, lane 4).
At least 7 differently migrating viral DNA replicons were detected in the LMW DNA
of the HPV18-E1HA and HPV18-Nluc cells by SB. The intensity of the bands in each
lane was quantified. The sum of the pixels obtained for a particular sample was set as
100%, and the quantity of the pixels of each band was calculated relative to 100%. The
most prevalent replicon of viral DNA accounted for approximately 80% in the HPV18-
E1HA cells and for approximately 50% in the HPV18-Nluc cells (Fig. 4D). Similar
results were obtained using the HPV18 cells, which exhibited five differentially
migrating HPV18 configurations, and approximately 80% of the viral DNA isolated from
the confluent cells corresponded to a single form detectable in the LMW DNA in the
nonconfluent cells (data not shown).
To further characterize the HPV18 genomic oligomers in our stable cell lines, we
performed a partial digestion analysis, which allowed us to distinguish between the
concatemeric and catenated episomes. Equal amounts of LMW DNA isolated from
the subconfluent HPV18-E1HA and HPV18-Nluc cells were digested with different
amounts of BglI, a single cutter enzyme for the HPV18 genome, and subjected to SB
(Fig. 5A). We observed that undigested HPV18 genomic forms disappeared gradually
in the presence of increased amounts of the BglI restriction endonuclease. Novel
forms of viral DNA molecules with different sizes, corresponding to linear mono-,
di-, tri-, and tetrameric forms of HPV18 genomes emerged. These molecules were
eventually converted into a single linear form, as a result of complete digestion.
Similar restriction patterns were obtained using other single cutters BglII and SdaI
(data not shown). Taken together, our results indicate that the HPV18 genomes are
arranged as head-to-tail concatemers in our HPV18-E1HA and HPV18-Nluc stable
cell lines, as it has been previously described for transient and maintenance
replication of the WT HPV18 genome (12).
To analyze the status of the viral DNA in more detail, 2D gel analysis of LMW DNA
from the HPV18-Nluc cells was performed (Fig. 5B). The analysis clearly showed closed
circular and open circular forms of monomeric and oligomeric episomal HPV18-Nluc
genomes.
Given that oligomerization of the viral genomes during transient replication is
accompanied by a change in the replication mechanism, as indicated by the analysis of
replication intermediates (10, 12), we were interested in the nature of the HPV repli-
cation mode in our stable cell lines, in which the oligomeric forms of the genome were
predominant. We used 2D gel analysis of the linearized HPV18-Nluc genomes from the
either transiently transfected U2OS or stable HPV18-Nluc cells (Fig. 5C). Our analysis
showed that, in accordance with the previously published data, two mechanisms
FIG 4 Legend (Continued)
covalently closed circular DNA; lin, linear DNA; oc, open circular DNA. (D) SB signals corresponding to the bands numbered in panel
C were quantified. The sum of the pixels obtained from each sample was set as 100%, and the intensity of each particular band was
calculated relative to 100%. The data are presented as average means  the SD of at least five different samples.
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coexisted in the transiently transfected U2OS cells. First, bidirectional replication via
theta-type intermediates was observed. Second, an unknown replication mechanism
that accompanied oligomerization of HPV18-Nluc genome was detected. As the ma-
jority of the viral genome in the HPV18-Nluc cells were in an oligomeric state (Fig. 4C
and 5A and B), the bidirectional theta-type of replication was almost nondetectable.
Taken together, our results show that two important changes transpire in the stable
cell lines continuously propagated at high cellular density. First, there is an increase in
the copy number of the HPV18 genomes. Second, there is a change in the structure of
the HPV18 replicons, indicating a switch in the replication mode, which is a feature
of the vegetative replication of this virus type.
Inhibition of CK2 kinase and E1 RNAi downregulates E1 protein in the stable
cell lines. Next, we downregulated the E1 helicase in the stable HPV18, HPV18-
FIG 5 The HPV18-E1HA and HPV18-Nluc cells carry head-to-tail concatemeric episomes that replicate via
non-theta-type intermediates. (A) LMW DNA was extracted via Hirt lysis from the subconfluent HPV18-E1HA and
HPV18-Nluc cells. Prior to SB, equal amounts of LMW DNA (20 g for HPV18-E1HA cells and 15 g for
HPV18-Nluc cells) were treated with 1 l of HindIII and the indicated amounts of BglI restriction endonucleases,
which serve as a noncutter and a single cutter, respectively. Reaction mixtures were incubated at 37°C for 30 min.
DNA molecules with sizes corresponding to single, dimeric, trimeric, and tetrameric linear forms are indicated as
1 lin, 2 lin, 3 lin, and 4 lin, respectively. ccc, covalently closed circular DNA; oc, open circular DNA. (B) LMW DNA
was isolated from the nonconfluent HPV18-Nluc cells and was subjected to neutral-neutral 2D analysis, using 0.4%
agarose in Tris-borate-EDTA (TBE) in the first dimension and 1.2% agarose plus ethidium bromide in TBE in the
second dimension. Viral DNA was detected using SB. Different forms of viral episomes from monomeric to
hexameric genomes were detected. ccc, covalently closed circular DNA; oc, open circular DNA. (C) LMW DNA was
isolated from the U2OS cells transiently transfected with the HPV18-Nluc genome (left panel) and from the
HPV18-Nluc cells (right panel). DNA was digested with BglI, which cuts the viral genomes once at the origin of
replication, and subjected to neutral-neutral 2D analysis as in panel B. Both the theta type (arrowhead) and the
non-theta type of replication intermediates (arrows) were observed in the transiently transfected cells, while the
non-theta type of replication intermediates prevailed in the HPV18-Nluc cells. Asterisks depict the almost fully
replicated HPV DNA.
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E1HA, and HPV18-Nluc cells. First, E1 expression was suppressed using the E1-
specific siRNAs. Since we could not analyze the level of E1 protein in the HPV18 or
HPV18-Nluc cells because of lack of a specific antibody, we applied qPCR to measure
the E1 mRNA expression levels in the cells treated with the E1 siRNAs for 2 and 5 days
(Fig. 6A). At 2 days after transfection, both siRNAs suppressed E1 mRNA expression by
at least 80% (Fig. 6A, left panel). However, the level of E1 transcript increased on day
5 of the experiment despite repeated siRNA delivery on day 3 after the first transfection
(Fig. 6A, right panel). These data could be explained by the inappropriate conditions for
efficient transfection of the siRNAs, since the cellular density substantially exceeded the
optimal level on day 3 of culturing.
FIG 6 Downregulation of the endogenous E1 protein expression was achieved by different treatments of the stable cell lines. (A) HPV18-E1HA,
HPV18-Nluc, and HPV18 cells were transfected with E1-specific or Neg. siRNA and propagated for 2 or 5 days (left and right panels, respectively).
In the case of prolonged culturing, the cells were transfected with the indicated siRNAs also on day 3 after the first transfection. E1 mRNA
expression levels were analyzed using qPCR in triplicate and normalized to the GAPDH expression levels. The data were calculated relative to the
normalized E1 mRNA expression level in the control cells transfected with Neg. siRNA (referred to as “1”). The data are expressed as average
means  the SD (*, P  0.05; **, P  0.01; ***, P  0.001). (B and D) HPV18-E1HA cells were either transfected with E1-specific siRNAs (B) or siCK2
or were treated with the CK2 inhibitor CX4945 (D). Cells were propagated for the indicated periods of time without subculturing. The HA-tagged
E1 protein was immunoprecipitated and analyzed by WB. GAPDH was used as a control. (C and E) The WB signals corresponding to the levels
of the E1 protein were quantified and expressed as percentages  the SD relative to the levels obtained in the control cells transfected with Neg.
siRNA (set as 100%). **, P  0.01; ***, P  0.001; n  3; ND, not detected. (F) Cell cycle profile of the HPV18-Nluc cells transfected with the siRNAs
and incubated for the indicated periods of time was determined using PI.
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The immunoblot assay showed a strong reduction in the E1 protein levels in
response to the E1 RNAi in the HPV18-E1HA cells (Fig. 6B, left panel, lanes 4 to 6 for
siRNA1 and lanes 7 to 9 for siRNA2). In addition to the results described above, an
increase in the copy number of the HPV18-E1HA genome was accompanied by an
2-fold increase in the E1 protein level in the confluent cells (Fig. 4C and 6B, lanes 1
to 3, and Fig. 6C).
We have previously demonstrated that inhibition of CK2 kinase leads to the
degradation of the E1 protein in transiently transfected U2OS cells (34). To determine
whether a similar phenomenon also occurs during HPV18 maintenance replication, we
tested E1 protein levels in the HPV18-E1HA cells inhibiting either the expression or
activity of CK2 kinase using CK2 RNAi or CX4945, respectively. Two different con-
centrations of CX4945, 6 and 9 M, were used. The level of the E1 protein was
examined using WB after 2 or 6 days of treatment (Fig. 6D). Both treatments resulted in
profound attenuation of the E1 protein level.
The WB signals obtained in different experiments were quantified, and the E1
protein level was set as 100% in the control cells (Fig. 6E). Similar to the E1-specific
siRNAs, the efficiency of CK2 RNAi was higher on day 2 of treatment, at which point
the E1 protein level dropped more than 90%. However, the efficiency of the RNAi
decreased in the dense cultures, which led to an increase in the E1 protein level up to
30% on day 6 of the experiment. In contrast, the degradation of the E1 protein
escalated over time in response to CX4945. Relative to the respective control, the E1
protein level decreased from 16% on day 2 to 7% on day 6 in response to 6 M CX4945,
and remained under the detectable limit on day 6 of the treatment with 9 M CX4945.
In addition, our data from qPCR and WB showed that, in contrast to that in the initial
amplification phase, E1 mRNA was more sensitive to E1 siRNA1 during the stable phase
of HPV18 genome replication (Fig. 2A and 6A and C), which could be a consequence of
the different levels of E1 transcripts expressed in each particular replication phase.
The cell cycle profile was analyzed in the HPV18-Nluc cells treated with the E1
siRNAs and incubated for 2, 4, and 6 days. E1 RNAi per se had no effect on the cell cycle,
but the percentage of cells in G0/G1 increased substantially on day 6, indicating cell
cycle arrest in the dense cultures (Fig. 6F).
Maintenance replication of the HPV18 genomes occurs mostly in an E1-
independent manner. To study the involvement of E1 in the maintenance phase of
HPV18 replication, E1 RNAi and CX4945 were applied to the HPV18, HPV18-E1HA,
and HPV18-Nluc cells cultured between sparse and subconfluent density for 7 days.
Treatment with E1 siRNA1 was combined with E2 overexpression to compensate for a
possible loss of E2, as observed in the transient replication experiments (Fig. 2A). The
SB analysis of LMW DNA showed no substantial alterations in HPV18 genome copy
numbers in the HPV18 and HPV18-E1HA cells (Fig. 7A). Similarly, E1 RNAi had no
effect on the copy number of the HPV18-Nluc genome in the HPV18-Nluc cells (Fig.
7B, left panel, lanes 1 to 4). Since the nonconfluent HPV18-Nluc cells exhibited
multiple mono- and oligomeric forms of viral DNA, we also analyzed the pattern of the
uncut HPV18-Nluc genome. Surprisingly, all the minor forms of the viral DNA, except
the dominant form, disappeared over time in response to E1 knockdown (Fig. 7B, left
panel, lanes 5 to 8, with the dominant replicon shown by an asterisk). Treatment with
CX4945 resulted in a more rapid loss of the same forms of viral DNA, which was
accompanied by a decrease in the overall copy number of HPV18-Nluc (Fig. 7B, right
panel, compare lanes 1 and 2 to lanes 3 and 4 for the linearized viral genome and lanes
5 and 6 to lanes 7 and 8 for the uncut HPV18-Nluc). However, the level of the dominant
replicon remained similar to that in the control cells. These results suggest that the
HPV18 genome is maintained at a stable level mostly via E1-independent mechanisms
in the U2OS-derived cells. However, there is also potential for an E1-dependent mode
of replication, which depends on the initial status of the viral DNA.
E1 is involved in the amplification of the HPV18 genome in confluent U2OS
cells. Our analysis showed that culturing of the stable cell lines at high cellular density
mimics, to some extent, the conditions required for the induction of HPV copy number
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in the terminally differentiating keratinocytes during the vegetative amplification of the
viral life cycle (Fig. 4C). However, these conditions stimulated not only an increase in
HPV18 genome copy number but also the appearance of multiple monomeric and
oligomeric forms of viral DNA in addition to the single form detected in the noncon-
fluent stable cell lines. To analyze the consequences of E1 downregulation during the
vegetative amplification phase, we analyzed the copy number and status of the HPV18
genomes in the stable cell lines propagated at high cellular density after administrating
E1-downgrading treatments.
HPV18-E1HA cells were cotransfected either with E1-specific siRNAs and E2-Flag
encoding construct or with CK2 and CK2= siRNAs. The cells were incubated for 6 days
without subculturing. LMW DNA was extracted and digested with either BglI or HindIII
restriction endonucleases producing linearized and uncut HPV18-E1HA genomes, re-
spectively, which were analyzed using SB (Fig. 8A and B).
Analysis of the linearized HPV18-E1HA genome revealed that the viral genome copy
number increased during the course of the experiment not only in the control cells
treated with scrambled negative (Neg.) siRNA (Fig. 8A, lanes 1 to 3), but also in the cells
treated with the E1 siRNAs (Fig. 8A, lanes 4 to 6 and lanes 7 to 8 for E1 siRNA1 and
siRNA2, respectively). However, the amount of the linearized HPV18-E1HA genome was
slightly lower in the cells treated with the more potent E1 siRNA1 (compare lanes 2 and
3 and lanes 5 and 6 in Fig. 8A).
Analysis of the uncut HPV18-E1HA genome showed an increase in the intensity of
the dominant replicon during propagation. However, E1 RNAi caused low levels or no
other minor viral DNA conformers to emerge, which represents monomeric and dimeric
forms of the viral genome. This effect was more noticeable in the case of E1 siRNA1
triggering more profound downregulation of E1 expression (Fig. 8A, compare lanes 12,
15, and 18).
A similar result was achieved using either CK2 siRNA or CX4549 treatment (Fig. 8B).
CK2 RNAi and drug had minor effect on the copy number of the HPV18-E1HA DNA, as
assessed by analyzing the linearized genome (Fig. 8B, lanes 1 to 8). However, the level
of the monomeric and dimeric viral DNA conformers emerging in dense culture was
reduced in response to CK2 RNAi and challenge with CX4945 after 6 days of culturing
(Fig. 8B, compare lane 12 to lanes 13, 15, and 16). Since CK2= knockdown did not affect
the stability of the E1 protein, the pattern of uncut viral DNA in the cells treated with
CK2= siRNA resembled that of the control (Fig. 8B, compare lanes 12 and 14).
FIG 7 Deficiency of E1 does not abrogate the stable replication of the HPV18 genomes. (A and B) The HPV18, HPV18-E1HA and
HPV18-Nluc cell lines were repeatedly treated either with E1 siRNA or CX4945 and propagated at low cellular density for 3, 6, or
7 days. LMW DNA was isolated and treated with BglI restriction endonuclease linearizing the HPV18 genomes. Also, LMW DNA of the
HPV18-Nluc cells was treated with HindIII to analyze the pattern of the uncut HPV18-Nluc genome (B). The DNA was analyzed using
SB. *, Dominant replicon of HPV18-Nluc.
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SB signals of the linearized and uncut dominant form of HPV18-HA DNA (band 4, as
shown in Fig. 4C) obtained from different experiments were quantified and set as 100%
in the control cells treated with either Neg. siRNA or dimethyl sulfoxide (DMSO) in the
case of RNAi or CX4945 challenge, respectively (Fig. 8C and D). The analysis revealed no
significant changes in the signals obtained from SB at each particular time point.
Similar experiments involving E1 RNAi and challenge with CX4945 were conducted
using HPV18-Nluc and HPV18 cells (Fig. 9A and C, respectively). The SB signals
corresponding to the linearized and major conformers of uncut viral genomes (domi-
nant band for the HPV18 cells and band 5 for the HPV18-Nluc cells, as shown in Fig.
4C) obtained in the E1 RNAi experiments were quantified (Fig. 9B). No significant
FIG 8 Stable replication of the HPV18-E1HA genome occurs via E1-dependent and E1-independent mechanisms. (A and B) The HPV18-E1HA cells of were
cotransfected with E1-specific or Neg. siRNA and E2-Flag-encoding construct (A) or CK2-specific siRNAs or treated with the indicated concentrations of CX4945
(B). Cells were propagated for the indicated periods of time without subculturing. LMW DNA was isolated via Hirt lysis; treated with either BglI or HindIII for
linearizing or not cutting the HPV18-E1HA genome, respectively; and analyzed using SB. Images were captured after short and long exposure times (A, upper
and lower panels, respectively). Monomeric closed circular (ccc), linear (lin), and open circular/dimeric closed circular (oc/2ccc) forms of HPV18-E1HA replicons
are indicated. (C and D) The SB signals corresponding to the linearized HPV18-E1HA genome or the major band of the uncut HPV18-E1HA DNA (numbered as
band 4) were quantified. The data are presented as percentages of the signals obtained in the LMW DNA isolated from the cells treated with Neg. siRNA,
incubated for 2 days and subjected to SB (set as 100%). The average means  the SD of at least three independent experiments are shown. NA, not analyzed.
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FIG 9 E1-dependent and E1-independent mechanisms of HPV18 replication are a common feature of different stable cell lines. (A and C) The HPV18-Nluc and
HPV18 cells were cotransfected with the E1-specific or Neg. siRNA and the E2-Flag encoding construct (A); alternatively, the cells were treated with 9 M
CX4945 (C). The cells were incubated for the indicated time without subculturing. LMW DNA was isolated by the Hirt extraction method; digested with BglI
or HindIII restriction enzymes to produce linearized or uncut HPV18 genomes, respectively; and analyzed using SB. Images were acquired with short and long
exposure times (C, upper and lower panels, respectively). Monomeric closed circular (ccc), linear (lin), and open circular/dimeric closed circular (oc/2ccc) forms
(Continued on next page)
Piirsoo et al. Journal of Virology
October 2020 Volume 94 Issue 20 e00674-20 jvi.asm.org 16












differences were observed. In general, the results were consistent with those of the
HPV18-E1HA cells with one exception. The HPV18-Nluc cells demonstrated higher
sensitivity to the treatment with CX4945, and the levels of the linearized HPV18-Nluc
genome, as well as the dominant replicon detected in the uncut viral DNA, decreased
over time (Fig. 9C, left panels).
Taken together, our data confirm the existence of at least two replication mecha-
nisms of the HPV18 genome in the dense cultures of U2OS cells. Some forms of the viral
DNA were efficiently replicated in the absence of the E1 helicase. However, other viral
DNA conformers replicated in an E1-dependent manner. Since these monomers and
oligomers form only a minor portion of the viral DNA in cells, E1 deficiency had no
significant effect on the overall copy number of the HPV18 genome.
E1 overexpression induces increase in HPV18 genome copy number in a cell
line-specific manner and rescues the E1 RNAi-induced phenotype. To analyze
whether the observed changes in the viral DNA pattern occur due to the downregu-
lation of E1 in the confluent HPV18 and HPV18-Nluc cells, we combined the E1 RNAi
with overexpression of the E1-siRNA-R constructs to compensate for the loss of E1. After
4 days of incubation, LMW DNA was isolated, treated with DpnI and BglI or HindIII to
analyze the linear and uncut HPV18 DNA, respectively, and subjected to SB (Fig. 10A).
SB analysis of the linearized HPV18 genome revealed that the overexpression of E1
up-regulated the overall copy number of the HPV18-Nluc genome but had no profound
effect on replication of the HPV18 genome (Fig. 10A upper left and right panels,
respectively). E1 RNAi inhibited the appearance of the multiple oligomeric replicons in
both cell lines grown under confluent conditions. However, the pattern and intensity of
the HPV18 replicons were restored in the cells treated with E1-specific siRNA combined
with the respective construct encoding the siRNA-resistant E1. These data show that the
E1 protein is responsible for the alterations in HPV18 replication in confluent cells.
To obtain deeper insight into the role of E1 in the stable replication of the HPV18
genome, we examined whether upregulation of E1 is a prerequisite for the increase in
the genome copy number and/or appearance of different monomeric and oligomeric
forms of the viral genome, as was observed during the vegetative amplification phase
of replication. The E1 and/or E2 proteins were overexpressed in the nonconfluent
HPV18-E1HA, HPV18, and HPV18-Nluc cells for 48 or 72 h until cultures reached
approximately 70% confluence. WB analysis showed that the levels of the overex-
pressed proteins were similar in all the cell lines (Fig. 10B). However, an E1-dependent
increase in HPV18-Nluc copy number, as well as the appearance of multiple forms of
the viral genome, was clearly detected only in the nonconfluent HPV18-Nluc cells (Fig.
10C, middle panel). The HPV18-E1HA and HPV18 cells had a slightly elevated viral
genome copy number only in the case of E1 and E2 coexpression (Fig. 10C, left and
right panels, respectively). However, overexpression of the viral replication proteins per
se was insufficient to induce the appearance of multiple viral DNA replicons specific to
the confluent cells. These data suggest that an increase in the E1 and/or E2 expression
levels is not the only factor required for induction of amplification of viral DNA in dense
cultures of the U2OS cells.
DISCUSSION
Numerous studies have identified E1 and E2 proteins as core factors for HPV genome
replication (reviewed in reference 2). Most of these studies, however, addressed only
the first stage of the HPV life cycle, the initial amplification of the genome. The roles of
the E1 and E2 proteins in the maintenance and productive phases of viral genome
replication have remained controversial. It has been suggested, but not formally shown,
that the roles of E2 in maintenance replication are to recruit the cellular ORC initiator
FIG 9 Legend (Continued)
of HPV replicons are indicated. (B) SB signals corresponding to the linearized and uncut forms of the HPV18 genomes (bands 5 for the HPV18-Nluc cells and
dominant band for the HPV18 cells) of the E1 RNAi experiments were quantified. The data are presented as percentages of the signals obtained in the samples
transfected with Neg. siRNA and incubated for 2 days (set as 100%).
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protein to the viral origin of replication and to promote partitioning of the HPV
genomes at mitosis (38). The function of E2 during vegetative amplification of the viral
genome has not been addressed. The roles of E1 in HPV replication are to recruit
cellular replication machinery to the origin of replication and to act as a helicase (6).
Several studies have shown that E1 is dispensable for the maintenance replication of
HPV16, while it is required in the case of HPV31 (9, 22–24). Surprisingly, one of these
studies found that HPV16 E1 was not required for initial replication either (9).
In the present article, we studied the contribution of HPV18 E1 in the initial
amplification, maintenance replication, and vegetative amplification of the viral ge-
nomes in U2OS cells. To facilitate the analysis of the endogenous E1 and E2 proteins
and quantification of the genome copy number, we generated a modified HPV18-
FIG 10 The overexpressed E1 regulates the HPV18 genome copy number in a cell line-specific manner and is capable of rescuing
the E1 RNAi-induced phenotype. (A) The HPV18 and HPV18-Nluc cells were cotransfected with Neg. or E1-specific siRNAs and
E1-siRNA1-R or E1-siRNA2-R expression constructs encoding the E1-HA protein. The cells were incubated for 4 days and
subjected to the isolation of LMW DNA via Hirt lysis. Prior to SB, the LMW DNA was treated either BglI or HindIII restriction
enzymes to produce linearized or uncut HPV18 genomes (upper and lower panels, respectively). (B and C) E1 and/or E2 proteins
were overexpressed in the HPV18-E1HA, HPV18, and HPV18-Nluc cells. The cells were propagated at low cellular density for
48 h. E2 was immunoprecipitated using anti-Flag M2 affinity resin. (B) The levels of the overexpressed E1 and E2 proteins were
analyzed with immunoblotting and anti-tag antibodies; GAPDH was used as a loading control. (C) LMW DNA was isolated; treated
with BglI or HindIII restriction enzymes to generate linearized or uncut HPV18 genomes, respectively; and analyzed using SB.
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E1HA-Nluc-E2Flag genome expressing Nluc, HA-tagged E1, and Flag-tagged E2 pro-
teins. These modifications did not change the replication capacity of the viral genome,
and the Nluc activity correlated adequately with the viral genome copy number. The
novel genome has been proven to be a useful tool for the investigation of the
endogenous E1 and E2, since both proteins encoded by this genome were detectable
by immunoblot assay using anti-tag antibodies. By using E1 RNAi, we showed that, in
accordance with the generally accepted understanding about HPV replication, E1 was
absolutely required for the initial amplification of the HPV18 genome. Surprisingly, the
E1 siRNAs also interfered with the E2-encoding transcript(s). This observation may be
explained by the fact that E1 and E2 are mostly expressed from the longest HPV18
transcript found in the transiently transfected U2OS and in the HPV18 clone 1.13 cells
(29). Both E1 siRNAs are specific for this transcript. We also observed a slightly reduced
level of E2 protein in E1-deficient cells treated with CK2 inhibitor CX4945, which likely
resulted from some stabilizing effect due to the physical interaction between these
proteins.
To address the question of whether E1 is required for the maintenance replication
of the HPV18 genomes, we generated three different U2OS-derived cell lines bearing
either the WT or the modified HPV18 genomes, each replicating as extrachromosomal
multicopy episomes: first, a cell line containing the WT HPV18 genome (HPV18 cells);
second, a cell line with a modified HPV18 genome containing the Nluc reporter to allow
the rapid detection of copy number changes (HPV18-Nluc cells); and third, a cell line
bearing an HPV18 genome expressing HA-tagged E1 to facilitate detection of endog-
enous E1 (HPV18-E1HA cells). The common feature of these cell lines is the predom-
inantly oligomeric status of the replicating viral genomes. However, oligomerization of
the viral genomes has been previously observed in most stable cell lines and in human
tissues containing episomal HPV genomes (12–15). Interestingly, oligomers of this
particular size are negligible during the initial amplification phase of HPV18 replication,
suggesting that, during the establishment of stable infection, some minor viral repli-
cons become the preferential substrates of the replication machinery, whereas others
(in particular, the monomeric forms) disappear over time.
First, we established that E1 is expressed in these cell lines. Using E1 RNAi, we
showed that the viral genome copy number did not change significantly when E1 was
efficiently knocked down in the HPV18-E1HA and HPV18 cells. We have recently
shown that CK2-mediated phosphorylation is needed for the stability of E1, as
indicated by the inhibition of CK2 expression or catalytic activity leading to the rapid
degradation of the E1 protein (34). Therefore, to further strengthen our argument, we
used CX4945-induced inhibition of CK2 catalytic activity and obtained similar results.
These data indicate that, despite the expression of E1 during the persistent infection
phase of the viral life cycle, it is dispensable for the replication of the oligomeric HPV18
genome at this stage in the analyzed cell lines. Indeed, it has been shown that several
cellular helicases can, in principle, take over the function of E1 and participate in the
replication of various HPV types (11, 39, 40). The reason for this phenomenon is unclear,
since both E1 and E2 proteins are present in the system, and there are therefore no
constraints on the origin activation by these viral proteins. Moreover, even overexpres-
sion of E1 and E2 proteins could not effectively trigger the replication of the oligomeric
HPV18 genomes in the HPV18-E1HA and HPV18 cells.
One possible explanation for this paradox may lie in the structure of the HPV
replicons during the maintenance replication phase. As described above, the viral
genomes are mostly oligomeric in our stable cell lines. We and others have previously
shown that the HPV replication mode changes upon oligomerization of the viral
genomes, from bidirectional replication involving theta-type intermediates to a mode
possibly involving DNA break-induced replication (10, 11). Consistent with these ob-
servations, we also showed that the predominant replication mode in our stable cell
lines was not bidirectional theta replication.
One of our established cell lines, HPV18-Nluc, contained, along with the oligomeric
forms, detectable amounts of monomeric viral genomes. In this case, we have dem-
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onstrated that suppression of E1 expression by E1 RNAi or use of the CK2 inhibitor
CX4945 led to the disappearance of the monomeric HPV18 replicons and other minor
oligomeric replicons from the system with the major replicons mostly unaffected. These
data indicate that two populations of HPV18 replicons can coreplicate during persistent
infection. One population, in our cell lines, the dominant one, replicates independently
of E1, whereas replication of other replicons is dependent on E1 and likely on E2. Since
E1-independent replication is likely under the control of the cellular replication ma-
chinery, it is possible that it occurs once per cell cycle, as Doorbar and colleagues
showed in the case of E1-independent HPV16 replication in keratinocytes (9). These
data also explain the conflicting results obtained regarding the synchrony of HPV
replication in the stable cell lines. One article reports that HPV16 replication occurs once
per cell cycle in W12 cells, whereas another study argues that HPV31 replication occurs
statistically once per cell cycle in CIN612 cells (8, 9). However, it has been shown that
HPV16 genomes are mostly oligomeric in W12 cells, whereas substantial amounts of
monomeric HPV31 genomes are retained in CIN612 cells.
Further, we studied the effect of the suppression of E1 function on the vegetative
replication of the HPV18 genome. We realize that U2OS cell line is not ideal model to
study the productive infection of HPV, which normally replicates in a keratinocyte
differentiation-dependent manner. However, culturing of the U2OS-derived stable cell
lines at high cellular density mimicked the keratinocytes surprisingly well in terms of
the events taking place during the vegetative replication of HPV, including the induc-
tion of the viral genome copy number, appearance of monomeric HPV genomes, and
increased expression of E1. We demonstrated that the appearance of monomeric
HPV18 genomes was abolished in E1-deficient cells, indicating that E1 is involved in the
vegetative replication of HPV18 genomes. However, because the monomeric forms
represent only a minor fraction of the overall viral DNA in cells, the lack of E1 function
had no significant effect on the overall HPV genome copy number in our stable cell
lines. Taken together, these data indicate the coexistence of E1-dependent and E1-
independent modes of HPV18 replication, which is consistent with the results obtained
in other cellular systems.
Based on our data and the data from other laboratories, we hereby propose a
model of E1 function during the HPV18 life cycle. Upon the initial infection, the
HPV18 genome becomes activated, and E1/E2-dependent replication leads to the
amplification of the genome in the cells followed by the expression of viral
oncogenes E6 and E7. Viral proteins, likely induced in combination with replication
stress accompanying the amplification of foreign DNA in the cell, trigger the
activation of the cellular recombination-dependent replication (RDR) machinery.
Activation of the RDR machinery, in turn, initiates homologous recombination-
dependent oligomerization of the viral genome, as circular replicons exhibit prob-
lems in completing the replication process. Depending on the strength of the RDR
induction, two possible scenarios can initiate the maintenance replication. First, if
the induction of RDR is sufficiently strong, it completely hijacks HPV genome
replication from E1 and E2. This scenario leads to either eventual integration of the
viral DNA into the host cell genome or generation of once-per-cell cycle replication
of oligomeric viral genomes as mammalian autonomously replicating sequence
elements. In either case, the fate of the infection is abortive, since monomeric
genomes cannot be produced during vegetative phase of the viral life cycle.
Second, if RDR induction is at an intermediate or low level, it partially takes over
viral genome replication, leading to a situation, in which the formed oligomeric viral
genomes replicate once per cell cycle, whereas E1- and E2-dependent replication of
monomeric HPV genomes persists, replicating statistically once per cell cycle. The
ratio between monomers and oligomers depends on the strength of the RDR
activity. Only the latter type of maintenance replication leads to productive infec-
tion.
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Plasmids. HPV18, HPV18-E1HA, and HPV18-Nluc genomes and their parental plasmids were de-
scribed previously (10, 12, 34). The HPV18-E1HA-Nluc-E2Flag genome was generated on the basis of the
HPV18-E1HA genome by inserting the sequences encoding the codon-optimized Nluc and 2A region of
the foot-and-mouth disease virus (FMDV) after the 72nd nucleotide in the E2 ORF, which corresponds to
the E1 stop codon. The full-length WT E2 ORF begins next to the 2A sequence. The Flag tag-encoding
sequence was inserted into the 5= end of the full-length E2 ORF after the first ATG. The resulting construct
encodes the HA-tagged E1 followed by Nluc fused with 24 amino acids of E2 in the N terminus and
self-processed FMDV-2A peptide in the C terminus, and the Flag-tagged E2 protein. The above-
mentioned HPV genomes were generated as minicircle plasmids in Escherichia coli strain ZYCY10P3S2T
using minicircle DNA technology as previously described (41).
The plasmid encoding the Flag-tagged E2 of HPV18 was generated by cloning the E2 ORF lacking the
1st ATG into the pCMV-Flag-4 vector (Sigma-Aldrich) between the HindIII and BamHI sites. The plasmid
encoding the HA-tagged E1 of HPV18 was described previously (42). To generate the E1 siRNA-resistant
HPV18-E1HA genomes and E1-HA expression vectors, the siRNA1-and siRNA2-specific sequences were
changed to GAATTCAACCTCCCACTTTTG and GCTATCACCAAGATTACAAGA, respectively (the changed
nucleotides are underlined). These substitutions did not change the amino acids of the siRNA1- and
siRNA2-resistant E1 proteins.
Cell culture. Human osteosarcoma cell line U2OS (ATCC no HTB-96) and its derivatives were
propagated in normal growth medium (NGM) containing Iscove modified Dulbecco medium (Pan
Biotech), 10% fetal calf serum, and 1% penicillin-streptomycin (Sigma-Aldrich). The cells were transfected
by electroporation (220 V and 975 F) using a Gene Pulser XCell system (Bio-Rad Laboratories). Approx-
imately 1.5 g of the WT or modified HPV18 minicircle genomes was used for transfection of 106 U2OS
cells.
The HPV18 stable cell line containing the extrachromosomal HPV18 genome was described
previously as clone 1.13 (28). The HPV18-Nluc stable cell line was generated on the basis of a 10.15 cell
line containing a chromosomally integrated firefly luciferase-encoding sequence. The HPV18-E1HA
stable cell line was established as a derivative of the U2OS cells. For the generation of the stable cell lines,
approximately 2  106 cells were cotransfected with 3 g of the respective HPV18 genome, together
with the pBABE-hygro plasmid at a ratio of 10:1. After 48 h of incubation, the cells were seeded at an
approximate density 3  103 cells/cm2 and propagated in the presence of 200 g/ml hygromycin B
(Sigma-Aldrich) until individual hygromycin B-resistant colonies developed. The colonies were selected
and cultured separately in NGM supplemented with 175 g/ml hygromycin B for 2 weeks with subse-
quent switching to pure NGM.
The seeding density of the stable cell lines was approximately 2  104 cells/cm2. Approximately 80%
confluent cell cultures contained nearly 6.9  104 cells/cm2, and the cell cultures with cellular density
greater than 8.5  104 cell/cm2 were considered confluent cells. U2OS cells and their derivatives were
treated with 6 or 9 M CX4945 (Santa Cruz Biotechnologies) or DMSO in NGM. The medium was
replenished every 2 days during all experiments. All cells were propagated at 37°C and 5% of CO2.
E1 and E2 overexpression studies. Approximately 106 of U2OS or stable cells were transfected with
300 ng of the plasmid encoding the HA-tagged E1 and/or with 200 ng of the Flag-tagged E2-encoding
construct. The cells were incubated for 2 or 3 days until they reached approximately 80% confluence and
then subjected to WB or SB analysis.
RNA interference. The following HPV18 E1-specific siRNAs containing a dTdT overhang were used:
E1 siRNA1 GAAUUCCACUAGUCAUUUUUG and E1 siRNA2 GUUAAGUCCACGGUUACAAGA (Microsynth)
(43). The sequences of the E1 siRNA1 and siRNA2 corresponded to the nucleotides 2440 to 2460 and 1237
to 1257 of the HPV18REF genome (Papillomavirus Episteme database, https://pave.niaid.nih.gov), re-
spectively. Scrambled Neg. and CK2 siRNAs were described previously (34). Cells were transfected with
20 nM siRNAs, together with the modified HPV18 genomes, if indicated, using electroporation. In the
case of prolonged experiments, 40 nM siRNA was added using Lipofectamine RNAiMax reagent (Thermo
Fisher Scientific) on day 3 after electroporation.
DNA isolation, restriction, and SB. Total and extrachromosomal DNA was extracted as previously
described (28). To analyze the pattern of the uncut WT or modified HPV18 genomes, LMW DNA was
treated with restriction endonucleases HindIII, SacI, or ScaI. The following amounts of LMW DNA were
used: HPV18-E1HA cells, 25 g; HPV18-Nluc cells, 15 g; HPV18 cells, 20 g; and U2OS, 20 g. An
analysis of the linearized HPV18 genomes was performed using 5 g of the LMW or total DNA treated
with restriction endonuclease BglI, BglII, or SdaI. In the case of the transiently replicating genomes, the
LMW or total DNA was also treated with DpnI to cut the bacterially methylated input DNA. All restriction
reactions were performed in FastDigest Green buffer (Thermo Fisher Scientific). DNA was separated on
0.6% agarose gel. Prior capillary transfer to the Hybond-N membrane (GVS), the DNA was denatured
by incubating the gel in 0.25 N NaCl for 10 min and solution A (0.5 M NaOH, 1.5 M NaCl) for 1 h, with
subsequent neutralization in solution B (1 M Tris [pH 7.4], 1.5 M NaCl) for 30 min at room temperature.
Transfer, DNA crosslinking, and hybridization with the linearized HPV18 genome labeled with [-
32P]dCTP were performed as previously described at hybridization temperature of 68°C.
A 2D analysis of HPV18-Nluc replicons and replication intermediates was performed as described
previously using 150 g of the uncut or BglI-digested LMW DNA (10, 44).
Immunoprecipitation and WB. Endogenous HA-tagged E1 expressed by the HPV18-E1HA or
HPV18-E1HA-Nluc-E2Flag genomes was immunoprecipitated as described previously using 106 tran-
siently transfected U2OS or HPV18-E1HA cells per sample (34). For the Flag-tagged E2 immunoprecipi-
tation, the subconfluent cells from day 4 or 5 posttransfection grown on a 10-cm plate were lysed in 3 ml
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of radioimmunoprecipitation assay buffer supplemented with cOmplete ULTRA protease inhibitor cock-
tail (Sigma-Aldrich). The lysates were homogenized with a 22-g syringe, incubated at 4°C for 30 min
under slow rotation, diluted 4-fold with a lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA,
1% Triton X-100), and incubated for an additional 30 min at 4°C under slow rotation. After centrifugation
for 10 min at 104  g and 4°C, the supernatants were transferred into new tubes and incubated overnight
with anti-Flag M2 affinity gel (Sigma-Aldrich) under slow rotation at 4°C. The immunocomplexes were
washed three times with 3 ml of the lysis buffer and subjected to immunoblot analysis. The following
antibodies were used: anti-HA-HRP clone 3F10 (Sigma-Aldrich, 1:1,500), anti-Flag-HRP clone M2 (Sigma-
Aldrich, 1:3,000), anti-GAPDH (Sigma-Aldrich, 1:5,000), and goat anti-mouse IgG conjugated with horse-
radish peroxidase (Invitrogen, 1:10,000). Signals were detected by exposure to X-ray film (AGFA) after
incubation with SuperSignal West Dura extended duration substrate (Pierce, endogenous E1 and E2
proteins) or WB detection reagent (GE Healthcare, overexpressed E1 and GAPDH).
RNA isolation and qPCR. The stable cell lines were transfected with Neg. or E1-specific siRNAs and
incubated for 2 or 5 days. Total RNA was isolated using a Direct-Zol RNA Miniprep Plus kit (Zymo
Research). Approximately 6 g of total RNA was treated with 3 l of Turbo DNase (Invitrogen) for 3 h at
37°C. DNase was inactivated by incubation of the samples at 75°C for 10 min in the presence of 15 mM
EDTA, and total RNA was precipitated with 7.5 M LiCl supplemented with 50 mM EDTA. Complementary
DNA was synthesized using 1 g of the total RNA and a RevertAid cDNA synthesis kit (Thermo Fisher
Scientific). The expression levels of the housekeeping gene GAPDH and HPV18 E1 transcripts were
measured in triplicate by quantitative PCR using 5HOT FIREPol Blend Master Mix with 12.5 mM MgCl2
(Solis Biodyne) and primers listed elsewhere (34).
Cell cycle analysis. Approximately 106 U2OS or stable cells were transfected with 20 nM Neg. or
E1-specific siRNAs (and 2 g of the HPV18 genome, if indicated), incubated for 3 or 5 days, and subjected
to the cell cycle analysis using propidium iodide (PI). The experimental procedures were performed as
previously described (34).
Luciferase assay. U2OS cells were cotransfected with the HPV18-E1HA-Nluc-E2Flag genome (2 g
per 106 cells), 20 nM siRNAs, and E1- and E2-encoding plasmids. The cells were seeded on 96-well plates
in four replicates; incubated for 2, 3, and 4 days; washed with PBS; and lysed in passive lysis buffer (40 l
per well; Promega) for 15 min at room temperature. The Nluc activity was measured by using a Nano-Glo
luciferase assay system and normalized with alkaline phosphatase activity measured using CSPD sub-
strate (Invitrogen) (in both cases, 10 l of the lysate was used for each measurement).
Statistical analysis. The P values for the two-tailed t test were based on assumed equal variances
and calculated using Excel software.
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